PMC:7605643 / 278-2032
Annnotations
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1078-1102 | Body_part | denotes | renin-angiotensin system | http://purl.obolibrary.org/obo/UBERON_0018229 |
T2 | 1104-1110 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T3 | 1136-1141 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T4 | 1155-1167 | Body_part | denotes | blood vessel | http://purl.obolibrary.org/obo/UBERON_0001981 |
T5 | 1155-1160 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T6 | 1161-1167 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/UBERON_0000055 |
T7 | 1576-1589 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 794-801 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T2 | 1104-1110 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T3 | 1136-1141 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T4 | 1155-1167 | Body_part | denotes | blood vessel | http://purl.org/sig/ont/fma/fma63183 |
T5 | 1442-1451 | Body_part | denotes | chemokine | http://purl.org/sig/ont/fma/fma241981 |
T6 | 1576-1589 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T4 | 0-8 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 370-378 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 405-413 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 506-514 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T8 | 700-704 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 711-720 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T10 | 1051-1055 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 1537-1549 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T12 | 1708-1716 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 652-657 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T3 | 724-730 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T4 | 1104-1110 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T5 | 1104-1110 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T6 | 1104-1110 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T7 | 1136-1141 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T8 | 1136-1141 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T9 | 1155-1167 | http://purl.obolibrary.org/obo/UBERON_0001981 | denotes | blood vessel |
T10 | 1155-1167 | http://www.ebi.ac.uk/efo/EFO_0000817 | denotes | blood vessel |
T11 | 1464-1473 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T12 | 1576-1589 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
T13 | 1733-1734 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 234-243 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T2 | 245-261 | Chemical | denotes | antihypertensive | http://purl.obolibrary.org/obo/CHEBI_35674 |
T3 | 598-609 | Chemical | denotes | Angiotensin | http://purl.obolibrary.org/obo/CHEBI_2719 |
T4 | 610-612 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T5 | 794-801 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T6 | 1084-1095 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T7 | 1425-1427 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T9 | 1432-1435 | Chemical | denotes | AGE | http://purl.obolibrary.org/obo/CHEBI_84123 |
T10 | 1456-1463 | Chemical | denotes | calcium | http://purl.obolibrary.org/obo/CHEBI_22984|http://purl.obolibrary.org/obo/CHEBI_29320 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1122-1153 | http://purl.obolibrary.org/obo/GO_1903522 | denotes | regulation of blood circulation |
T2 | 1122-1132 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
T3 | 1136-1153 | http://purl.obolibrary.org/obo/GO_0008015 | denotes | blood circulation |
T4 | 1456-1473 | http://purl.obolibrary.org/obo/GO_0019722 | denotes | calcium signaling |
T5 | 1464-1473 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T6 | 1537-1549 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-193 | Sentence | denotes | COVID-19, emerged at the end of 2019 have dramatically threatened the health, economy, and social mobility of people around the world and till date no medication is available for its treatment. |
T8 | 194-414 | Sentence | denotes | An amazing herb, Nigella sativa, having antiviral, antihypertensive, anti- diarrhoeal, analgesics, and anti-bacterial properties, needs to be explored for its efficacy against SARS-CoV-2, the causative agent of COVID-19. |
T9 | 415-540 | Sentence | denotes | In-silico studies were carried out to understand the role of its bioactive constituents in COVID-19 treatment and prevention. |
T10 | 541-658 | Sentence | denotes | Firstly, the disease network was prepared by using ACE2 (Angiotensin-II receptor), as it is the entry site for virus. |
T11 | 659-731 | Sentence | denotes | It was used to decipher the mechanism of SARS-COV-2 infection in humans. |
T12 | 732-837 | Sentence | denotes | Second, the target receptors for N. sativa were predicted and protein interaction studies were conducted. |
T13 | 838-927 | Sentence | denotes | Further, docking studies were also performed to analyse it for treatment purpose as well. |
T14 | 928-1182 | Sentence | denotes | This study concludes that pathways undertaken by N. sativa bioactive constituents were similar to the pathways followed in SARS-COV-2 pathology, like renin-angiotensin system, kidney functions, regulation of blood circulation, blood vessel diameter, etc. |
T15 | 1183-1334 | Sentence | denotes | Also, in docking studies, the constituents of N. sativa, α-hederin, Thymohydroquinone and Thymoquinone were observed to be efficiently binding to ACE2. |
T16 | 1335-1611 | Sentence | denotes | Also, the bioactive phytoconstituents are involved in molecular pathways like HIF1, VEGF, IL-17, AGE-RAGE, chemokine and calcium signaling pathways which can be majorly helpful in combating hypoxia and inflammation caused due to compromised immune system and oxidative stress. |
T17 | 1612-1754 | Sentence | denotes | Therefore, N. sativa standardized extract having the above phytoconstituents could be useful in COVID-19 and hence opens a new treatment line. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 1525-1532 | Phenotype | denotes | hypoxia | http://purl.obolibrary.org/obo/HP_0012418 |
T2 | 1594-1610 | Phenotype | denotes | oxidative stress | http://purl.obolibrary.org/obo/HP_0025464 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
32 | 592-596 | Gene | denotes | ACE2 | Gene:59272 |
33 | 1078-1083 | Gene | denotes | renin | Gene:5972 |
34 | 1329-1333 | Gene | denotes | ACE2 | Gene:59272 |
35 | 1419-1423 | Gene | denotes | VEGF | Gene:83785 |
36 | 110-116 | Species | denotes | people | Tax:9606 |
37 | 370-380 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
38 | 724-730 | Species | denotes | humans | Tax:9606 |
39 | 765-774 | Species | denotes | N. sativa | Tax:555479 |
40 | 977-986 | Species | denotes | N. sativa | Tax:555479 |
41 | 1051-1061 | Species | denotes | SARS-COV-2 | Tax:2697049 |
42 | 1229-1238 | Species | denotes | N. sativa | Tax:555479 |
43 | 1623-1632 | Species | denotes | N. sativa | Tax:555479 |
44 | 211-218 | Species | denotes | Nigella | Tax:555479 |
45 | 1240-1249 | Chemical | denotes | α-hederin | MESH:C010177 |
46 | 1251-1268 | Chemical | denotes | Thymohydroquinone | MESH:C003465 |
47 | 1273-1285 | Chemical | denotes | Thymoquinone | MESH:C003466 |
48 | 1456-1463 | Chemical | denotes | calcium | MESH:D002118 |
49 | 0-8 | Disease | denotes | COVID-19 | MESH:C000657245 |
50 | 405-413 | Disease | denotes | COVID-19 | MESH:C000657245 |
51 | 506-514 | Disease | denotes | COVID-19 | MESH:C000657245 |
52 | 700-720 | Disease | denotes | SARS-COV-2 infection | MESH:C000657245 |
53 | 1525-1532 | Disease | denotes | hypoxia | MESH:D000860 |
54 | 1537-1549 | Disease | denotes | inflammation | MESH:D007249 |
55 | 1708-1716 | Disease | denotes | COVID-19 | MESH:C000657245 |